- Home
- BMRC vs KALV Comparison
BMRC vs KALV Comparison
Compare BMRC & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRC
- KALV
- Stock Information
- Founded
- BMRC 1989
- KALV N/A
- Country
- BMRC United States
- KALV United States
- Employees
- BMRC N/A
- KALV N/A
- Industry
- BMRC Major Banks
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- BMRC Finance
- KALV Health Care
- Exchange
- BMRC Nasdaq
- KALV Nasdaq
- Market Cap
- BMRC 334.0M
- KALV 362.2M
- IPO Year
- BMRC N/A
- KALV N/A
- Fundamental
- Price
- BMRC $23.70
- KALV $8.75
- Analyst Decision
- BMRC Strong Buy
- KALV Strong Buy
- Analyst Count
- BMRC 3
- KALV 7
- Target Price
- BMRC $28.00
- KALV $27.00
- AVG Volume (30 Days)
- BMRC 54.3K
- KALV 319.9K
- Earning Date
- BMRC 01-27-2025
- KALV 03-10-2025
- Dividend Yield
- BMRC 4.21%
- KALV N/A
- EPS Growth
- BMRC N/A
- KALV N/A
- EPS
- BMRC N/A
- KALV N/A
- Revenue
- BMRC $59,368,000.00
- KALV N/A
- Revenue This Year
- BMRC N/A
- KALV N/A
- Revenue Next Year
- BMRC $13.55
- KALV N/A
- P/E Ratio
- BMRC N/A
- KALV N/A
- Revenue Growth
- BMRC N/A
- KALV N/A
- 52 Week Low
- BMRC $14.11
- KALV $7.30
- 52 Week High
- BMRC $27.11
- KALV $16.88
- Technical
- Relative Strength Index (RSI)
- BMRC 50.49
- KALV 51.87
- Support Level
- BMRC $23.10
- KALV $7.30
- Resistance Level
- BMRC $24.00
- KALV $9.16
- Average True Range (ATR)
- BMRC 0.79
- KALV 0.41
- MACD
- BMRC 0.07
- KALV 0.07
- Stochastic Oscillator
- BMRC 66.79
- KALV 78.17
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.